Spring direct naar de hoofdnavigatie of de inhoud
‘In the end it's all about the value that the patent adds to the product.’
Mark Einerhand

Mark Einerhand

  • Life Sciences
  • European and Dutch Patent Attorney
  • Partner

Mark Einerhand has been active in the patent world since 1998, when he made the switch from a biotech startup to V.O.

Mark’s career started in science. After his studies of molecular biology at the University of Amsterdam, he took his PhD in medical science inLeiden, in 1992. He was a visiting scientist at Cornell University in New York and the MRC at Mill Hill in London.

Continue reading

His particular expertise lies in the field of medical (bio)technology, diagnostics and medicines. Because of his background at Introgene/Crucell, Mark has a special affinity with Life Science startups. He has a wide experience in patent cases before the court in The Hague.

Working experience

  • Patent Attorney, V.O. (1998-present)
  • IntroGene (now Crucell), Rijswijk (1995)
  • Post-Doc at Leiden University (1993)
  • Medical Research Council, Mill Hill, London (1992)
  • Visiting Scientist, Cornell University New York (1992)

Education

  • PhD in Medicine, Leiden University (1992)
  • MSc in Biochemistry, University of Amsterdam (1987), Major in Molecular Oncology, Dutch Cancer Institute

Publications

  • Co-author of article ‘The patentability of stem cells in Europe’, IAM Life Sciences 2015.
    Einerhand, M.P.W. (2011): Advance offering of generics found to infringe. Managing Intellectual Property: Vol 205: page: 87.
  • Einerhand M.P.W. (2010): A contribution to: Legal and intellectual property issues associated with stem cells. In: Stem Cells; scientific facts and fiction, (C. Mummery; I. Wilnut, A van de Stolpe and
    B.A.J. Roelen), Academic Press: Elsevier.
  • Einerhand M.P.W. and van Melle, J (2004): Patenting of inventions in the field of bio-informatics.
    In: The new avenues in Bioinformatics, (Seckbach, J and Rubin, E eds), Kluwer Academic Publishers, the Netherlands.
  • Principle inventor on Patents and Patent Applications: Einerhand, M.P.W. and Valerio (1997). WO 98/32870: US 6,232,105: A conditional replication and expression system. Einerhand, M.P.W. and Valerio (1997). WO 99/32647: Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into chromosomal DNA of target cells in gene therapy. Einerhand, M.P.W. and Valerio (1996). WO98/24924: NZ 336185:
  • Transduction of primate hemopoietic repopulating stem cells. Einerhand, M.P.W. and Valerio (1995). WO 97/20943: US 6,140,103: Regulated protein expression in stably transfected mammalian cells. Einerhand, M.P.W. (1992) Gene transfer into hemopoietic stem cells: prospects for human gene therapy. University of Leiden.

Professional & Community Activities

  • Member of the Steering Committee World IP Forum 2015
    Former member of the European Qualifying Examination committee III

Languages

  • English
  • Dutch
  • German

Also see these experts

Jetze Beeksma

Jetze Beeksma

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
Eline van Kappel

Eline van Kappel

  • European and Dutch Patent Attorney
  • Associate
More experts

News

Podium – Tagworks Pharmaceuticals

In this section we give a stage to start-ups and scale-ups that develop groundbreaking products or services. This time: Tagworks Pharmaceuticals from Nijmegen.Continue reading

Innovative idea? Enter the first NL Startup Competition and win €10,000 in prize money!

Groundbreaking ideas can change the world. Does your startup focus on social impact, energy transition, digital progress or solutions for the circular economy? Then enter the first ever NL Startup Competition and win € 10,000 prize money, valuable networking opportunities and new knowledge and inspiration. V.O. Patents & Trademarks is pleased to support this competition […]Continue reading

RVO helps entrepreneurs do business

Entrepreneurs make the Netherlands economically stronger and society increasingly sustainable. The Netherlands Enterprise Agency (RVO) contributes to this by encouraging them to invest in solutions to societal challenges.Continue reading

Events

JCI Flemish-Brabant Young Entrepreneur of the Year 2024

De Hoorn, Sluisstraat, Leuven, Belgium

JCI Flemish-Brabant Young Entrepreneur of the Year. Our society is constantly changing. And let that be precisely the goal of Junior Chamber International ("JCI"): to bring about positive changes in our society.

Continue reading

Knowledge for Growth 2024

Flanders Meeting & Convention Center Antwerp, Koningin Astridplein, Antwerp, Belgium

The crème de la crème of the Belgian life sciences community is present at flanders.bio's annual Knowledge for Growth conference, which brings together decision-makers from the biotech, pharma and medtech, agriculture and chemical industries, as well as investors, universities, top research institutions, policy makers and competence providers.

Continue reading

INTA Annual Meeting 2024

Georgia World Congress Center, Andrew Young International Boulevard Northwest, Atlanta, Georgia, USA

Meet the most influential trademark professionals from around the world and from all industries at the largest gathering of its kind at INTA's annual meeting.

Continue reading